Related Experiment Video

Updated: Jul 31, 2026

Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers
12:30

Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers

Published on: August 12, 2014

A novel approach and a novel mechanism for stealthing gene delivery vehicles

T Wickham1

  • 1Gen Vec, Incorporated, 65 West Watkins Mill Road, Gaithersburg, Maryland 20878, USA. twickham@genvec.com

Molecular Therapy : the Journal of the American Society of Gene Therapy
|August 19, 2000
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA
06:53

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

Published on: December 26, 2015

Development of Mesenchymal Stem Cell Membrane-Enveloped Nanovesicles for Enhanced Gene Delivery
10:00

Development of Mesenchymal Stem Cell Membrane-Enveloped Nanovesicles for Enhanced Gene Delivery

Published on: February 17, 2026

Related Experiment Videos

Last Updated: Jul 31, 2026

Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers
12:30

Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers

Published on: August 12, 2014

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA
06:53

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

Published on: December 26, 2015

Development of Mesenchymal Stem Cell Membrane-Enveloped Nanovesicles for Enhanced Gene Delivery
10:00

Development of Mesenchymal Stem Cell Membrane-Enveloped Nanovesicles for Enhanced Gene Delivery

Published on: February 17, 2026

Related Concept Videos

In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...

Articles linked to this work by shared authors, journal, and citation graph.

Head injuries in infants: the risks of bouncy chairs and car seats.

Archives of disease in childhood·2002

Adenovirus as a gene therapy vector for hematopoietic cells.

Cancer gene therapy·2000

Optimizing cardiovascular gene therapy: increased vascular gene transfer with modified adenoviral vectors.

Archives of surgery (Chicago, Ill. : 1960)·2000

The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses.

Journal of virology·1998

Multiple adenovirus serotypes use alpha v integrins for infection.

Journal of virology·1994

Bioreactor development for production of viral pesticides or heterologous proteins in insect cell cultures.

Annals of the New York Academy of Sciences·1990

Pre-clinical validation of AAV-mediated gene therapy for KCNV2 retinopathy improves visual function and expression in mouse and patient models.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

LNP-formulated dbDNA™ vaccines elicit durable humoral and cellular immunity with distinct kinetics to mRNA in non-human primates.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Targeted Epigenetic Reactivation strategies as new treatments for Prader-Willi Syndrome: Achievements and Challenges.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Catestatin peptide ameliorates tauopathy and amyloidogenesis via adrenergic inhibition.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

p38 MAPK inhibition safeguards genome integrity during gene editing of hematopoietic stem and progenitor cells.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Development of CRISPR_SCD001, an Autologous Hematopoietic Stem Cell Gene Therapy for Sickle Cell Disease after CRISPR-Cas9 Mediated Correction.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Parvalbumin interneurons and dentate gyrus homeostatic dysregulation shape epileptogenesis in Angelman syndrome model mice.

bioRxiv : the preprint server for biology·2026

Enhanced hemocompatibility and cytocompatibility of halloysite nanotubes via the formation of a protein corona.

Biomaterials science·2026

Near-Infrared Light-Activated Polydopamine Nanoparticles Conjugated With Transferrin Peptides for Enhanced Brain Accumulation.

Advanced healthcare materials·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us